Mesoblast (MESO) Total Current Liabilities (2017 - 2025)

Mesoblast's Total Current Liabilities history spans 7 years, with the latest figure at $42.0 million for Q2 2023.

  • For Q2 2023, Total Current Liabilities fell 18.28% year-over-year to $42.0 million; the TTM value through Jun 2023 reached $42.0 million, down 18.28%, while the annual FY2023 figure was $42.0 million, 18.28% down from the prior year.
  • Total Current Liabilities for Q2 2023 was $42.0 million at Mesoblast, down from $51.4 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $94.3 million in Q2 2021 and bottomed at $42.0 million in Q2 2023.
  • The 5-year median for Total Current Liabilities is $51.4 million (2022), against an average of $64.4 million.
  • The largest annual shift saw Total Current Liabilities soared 103.34% in 2020 before it plummeted 45.51% in 2022.
  • A 5-year view of Total Current Liabilities shows it stood at $44.3 million in 2019, then skyrocketed by 103.34% to $90.1 million in 2020, then increased by 4.58% to $94.3 million in 2021, then tumbled by 45.51% to $51.4 million in 2022, then decreased by 18.28% to $42.0 million in 2023.
  • Per Business Quant, the three most recent readings for MESO's Total Current Liabilities are $42.0 million (Q2 2023), $51.4 million (Q2 2022), and $94.3 million (Q2 2021).